David B. Whitman
9Patents
5h-index
23Co-inventors
63Inventor score
Filing activity: Mar 25, 1992 → May 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5648368A | Fibrinogen receptor antagonists | Chemistry; Metallurgy | 33 | Expired |
| US5264420A | Fibrinogen receptor antagonists | Chemistry; Metallurgy | 29 | Expired |
| US8669272B2 | 2,5-disubstituted piperidine orexin receptor antagonists | Chemistry; Metallurgy | 24 | Active |
| US8263586B2 | OXO bridged diazepan orexin receptor antagonists | Human Necessities | 19 | Active |
| US8685961B2 | Diazepan orexin receptor antagonists | Chemistry; Metallurgy | 19 | Active |
| US11046707B2 | Spiropiperidine derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US7595337B2 | Mitotic kinesin inhibitors | Human Necessities | 0 | Expired |
| US11878982B2 | Spiropiperidine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US7402577B2 | Androstane 17-beta-carboxamides as androgen receptor modulators | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.